Anthony Taparo - Feb 10, 2022 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Role
Chief Growth Officer
Signature
/s/ Jennifer Baldock, Attorney-in-Fact
Stock symbol
SGRY
Transactions as of
Feb 10, 2022
Transactions value $
-$90,552
Form type
4
Date filed
3/2/2022, 03:48 PM
Previous filing
May 10, 2021
Next filing
Mar 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGRY Common Stock Sale -$296K -5.65K -5.2% $52.28 103K Feb 28, 2022 Direct F1, F2
transaction SGRY Common Stock Award $205K +4.88K +4.73% $42.04 108K Feb 10, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 24, 2022.
F2 The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 Shares issued based on 2021 performance under performance stock unit awards granted to the Reporting Person on March 10, 2021. Shares will vest in two equal annual installments on each of the first two anniversaries of February 10, 2022.